$AIP

Arteris Q2 2026 Earnings Call Transcript - Arteris (NASDAQ:AIP)

Arteris (AIP) reported Q2 2026 revenue of $24.1M, up 46% YoY, with annual contract value plus royalties at $99.5M, a 44% increase. The company raised $72M via ATM and expects non-GAAP profitability by year-end. Q3 revenue is projected at $24-25M, with full-year guidance raised to $95-98M. CFO Nick Hawkins announced his retirement, to be succeeded by Saurabh Sinha in September 2026.

Original reporting
Published Oct 12, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 1:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AIP
Bullish
medium confidence
Mentioned
$AIP
Relevance
4/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$AIPBullishMed
01

Why it matters

The actionable items for traders are the company’s Q3 revenue and ACV royalty expectations and the raised full-year 2026 revenue guidance, alongside cash balance and CFO transition details.

02

Market read

Guidance and record royalty metrics can drive near-term positioning in semiconductor infrastructure IP, especially for investors tracking AI/HPC-related design wins.

03

What to watch

The transcript excerpt emphasizes ACV/royalties and design starts, but traders should scrutinize gross margin trajectory, cash flow conversion, and whether the ATM-funded investment plan accelerates revenue sustainably into 2027.

Relevance 4/10Novelty 4/10Timing: during/after the Q2 2026 earnings call, with Q3 and full-year guidance provided

Background

The piece is an earnings call transcript summarizing Arteris Q2 2026 performance, KPI highlights, and management commentary on demand drivers and outlook.

Company-level read

Ticker impact

$AIPBullishMedium confidence
Context

Arteris reported Q2 2026 results and raised full-year 2026 revenue guidance to $95 to $98 million, plus Q3 revenue and ACV royalty outlook.

Expected impact

Likely upward bias as the market prices in stronger 2026 revenue and royalty momentum.

Evidence & confidence

The article includes specific, company-issued guidance and record KPI levels (ACV plus royalties, revenue, and RPO/backlog) that typically drive near-term sentiment and revisions.

Market effects

Strength in semiconductor IP and NoC/interconnect demand tied to AI/HPC could support sentiment for adjacent infrastructure IP providers.

Limited direct regional read-through; primarily US-listed semiconductor software/IP sentiment.

AI infrastructure buildout narrative may reinforce global demand expectations for chiplet and data-movement IP.

Counterpoint

Record KPIs and guidance raises may still be offset by customer concentration risk, longer design-cycle timing, or variability in hyperscaler/semiconductor design activity.

Key entities

  • Arteris

    NASDAQ-listed semiconductor IP provider reporting Q2 2026 results and issuing Q3 and full-year 2026 guidance.

  • Nick Hawkins

    Outgoing CFO who reported cash balance and announced retirement; successor named.

  • Saurabh Sinha

    Incoming CFO starting September 2026.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to

$XYLHigh

JPMorgan downgrades Xylem stock rating on guidance cut, slower orders

JPMorgan downgraded Xylem (NYSE:XYL) to Underweight, cutting its price target to $90.00 from $118.00. The company's Q3 results missed estimates, leading to lowered 2026 guidance due to slower revenue conversion. Xylem's stock is near its 52-week low, down 37% over the past year. The company announced a 2027 re-segmentation to improve strategic focus. JPMorgan expects underperformance over the next 12 months but notes long-term value for sustainability-focused investors.

$DBHighAI 8/10

Deutsche Bank Q3 Profit, AuM Rises; Confirms FY26 Outlook

Deutsche Bank reported Q3 net profit of €1.85B, up 2% YoY, with EPS at €0.94 (+6%) and net revenues at €8.34B (+4%). AuM rose to €2.0T. The bank confirmed its FY26 outlook and expects to exceed a 13% RoTE target by 2028. Shares traded at $32.42, up 0.93%.